Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed study descriptions related to Olaparib monotherapy for BRCA mutated ovarian cancer and the addition of new registry identifiers and collaborators. The revision number has also been updated.SummaryDifference13%
- Check16 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.2%
- Check24 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and the last update date has changed to March 25, 2025. The previous version (v2.14.2) and its estimated update date have been removed.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check67 days agoChange DetectedThe webpage has updated its date references, replacing older dates with new ones for February 2025, while removing previous dates from November 2024.SummaryDifference1.0%
- Check74 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.